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Neuregulin 1-ErbB module in 
C-bouton synapses on somatic 
motor neurons: molecular 
compartmentation and response to 
peripheral nerve injury
Anna Casanovas, Sara Salvany, Víctor Lahoz, Olga Tarabal, Lídia Piedrafita, 
Raimundo Sabater, Sara Hernández, Jordi Calderó & Josep E. Esquerda
The electric activity of lower motor neurons (MNs) appears to play a role in determining cell-
vulnerability in MN diseases. MN excitability is modulated by cholinergic inputs through C-type 
synaptic boutons, which display an endoplasmic reticulum-related subsurface cistern (SSC) adjacent 
to the postsynaptic membrane. Besides cholinergic molecules, a constellation of proteins involved 
in different signal-transduction pathways are clustered at C-type synaptic sites (M2 muscarinic 
receptors, Kv2.1 potassium channels, Ca2+ activated K+ [SK] channels, and sigma-1 receptors [S1R]), 
but their collective functional significance so far remains unknown. We have previously suggested that 
neuregulin-1 (NRG1)/ErbBs-based retrograde signalling occurs at this synapse. To better understand 
signalling through C-boutons, we performed an analysis of the distribution of C-bouton-associated 
signalling proteins. We show that within SSC, S1R, Kv2.1 and NRG1 are clustered in highly specific, 
non-overlapping, microdomains, whereas ErbB2 and ErbB4 are present in the adjacent presynaptic 
compartment. This organization may define highly ordered and spatially restricted sites for different 
signal-transduction pathways. SSC associated proteins are disrupted in axotomised MNs together with 
the activation of microglia, which display a positive chemotactism to C-bouton sites. This indicates that 
C-bouton associated molecules are also involved in neuroinflammatory signalling in diseased MNs, 
emerging as new potential therapeutic targets.
Skeletal muscle contractions mediating motor behaviour involves the coordinated activity of distinct brain stem 
and spinal cord motor neuron (MN) populations. The firing rates of individual MNs results from the integration 
of a variety of excitatory and inhibitory MN synaptic inputs, which involve a range of different neurotransmit-
ter systems. During rhythmic motor behaviour (e. g. locomotion), the highly organized pattern of MN activ-
ity is modulated by cholinergic inputs1. These are delivered through C-type synaptic boutons originating from 
spinal interneurons. C-boutons are intriguing synaptic structures that are present in α - (but not in γ -) MNs, 
and that were first morphologically identified over 45 years ago2. C-boutons are unusually large nerve terminals 
(3–5 μ m long) which contain a high number of densely packed, round clear synaptic vesicles. In the postsynaptic 
region, C-terminals display a unique structure, consisting of a subsurface cistern (SSC) immediately adjacent 
(at 10–20 nm distance) to the MN membrane, and associated with a stack of underlying lamellae of endoplas-
mic reticulum (ER). There has recently been increased interest in C-boutons. After recognizing the choliner-
gic phenotype of C-boutons and their association with M2 muscarinic receptors3,4, other molecular aspects of 
these synapses, such as the expression of: voltage-gated K+ channels Kv2.15, Ca2+ activated K+ (SK) channels6, 
vesicle-associated membrane protein 2 (VAMP-2)3 and sigma-1 receptors (S1Rs)7, have been described. The 
gap junction protein connexin 32 has also been localized postsynaptically at the SSC8,9. The neuronal origin 
of C-bouton inputs was recently identified as a small cluster of cholinergic interneurons (VOc interneurons) 
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located near the central canal of the spinal cord, which modulate MN activity during locomotor behaviour1,10. 
Metabotropic M2 transmission in C-type synapses may inhibit Ca2+ dependent K+ channels, reducing the spike 
afterhyperpolarization,  instead of after hyperpolarization and enhancing MN firing frequency through a local 
intermediary effect of [Ca2+]in1,10.
The neuregulin-1 (NRG1) family includes more than 15 membrane-associated and secreted growth factors 
generated by alternative RNA splicing that interact with ErbB receptor tyrosine kinases. All NRG1 isoforms share 
an epidermal growth factor (EGF)-like signalling domain, and control many aspects of development. In the nerv-
ous system, the most abundant forms of NRG1 are types I and III. These, have been detected in MNs, dorsal root 
ganglion (DRG) neurons and, in particular in glia. NRG1 is involved in glia-axon interactions (myelination), the 
development of motor endplates, neuronal migration, synaptogenesis and plasticity in the CNS11–14. NRG1 is also 
involved in psychiatric disorders, including schizophrenia15,16. In a study examining the expression of NRG1 in 
phrenic spinal cord MNs, it was reported that this trophic protein is expressed in nearly all cholinergic nerve ter-
minals17; however, its precise subcellular localization was not addressed by these investigators. We have recently 
examined this issue and found that NRG1 is associated with C-boutons, concentrated in postsynaptic sites within 
the ER at the SSC18. We have also demonstrated that ErbB2 and ErbB4 receptors are present in the presynaptic 
compartment, suggesting that NRG1 acts as a retrograde signalling molecule in C-type synapses. C-boutons are 
scarcely investigated structures19, which have been reported to suffer plastic changes in sick MNs after spinal cord 
injury20,21, peripheral nerve lesion22, and amyotrophic lateral sclerosis (ALS)18,23–29. In addition, mutations in S1R 
are considered risk factors for familial ALS, and abnormal accumulations of this protein in C-terminals have also 
been observed in patients with sporadic ALS30–32. Altered SSCs also appear to be present in ALS-linked mutations 
of vesicle-associated membrane protein-associated protein B (VAPB, ALS8), which is abnormally targeted to C 
boutons33.
The relevance of the NRG1/ErbB pathway in MN diseases has been further underlined by the discovery of a 
new type of familial ALS caused by a loss of function mutation of ErbB434, and by the reported neuroprotective 
effects of NRG1 supplementation35 and/or altered NRG1 expression36 in ALS mice. MNs in oculomotor nuclei, 
which are spared in ALS, lack both C-boutons and SSC-associated NRG14,18.
Thus, at C-type synaptic sites, in addition to the presence of cholinergic molecules, a constellation of proteins 
involved in different signal-transduction pathways are specifically clustered, although their functional signifi-
cance remains largely unknown. In order to better understand synaptic signalling though C-boutons, we under-
took a structural analysis of the spatial organization of distinct C-bouton-associated signalling proteins, and 
especially the NRG1-ErbBs module, in different MN populations. We also examined changes in NRG1-ErbB 
expression during development and following peripheral nerve injury.
Results
Ultrastructure of C-bouton synapse in mouse spinal cord MNs. C-boutons can be morphologically 
distinguished from other afferent synaptic terminals contacting MN soma or dendrites in the spinal cord ventral 
horn. The C-bouton presynaptic element contains spherical and electron lucent synaptic vesicles, some endo-
some-like bodies and mitochondria. In the postsynaptic compartment, and in close apposition with the post-
synaptic membrane, the ER-related SSC is the main structural hallmark of C-boutons. The distance between the 
SSC and postsynaptic membrane is about 10–15 nm. C-boutons with large SSCs were also observed in MNs of 
newborn (P1) animals (Supplementary Fig. 1a–d). Our observations are consistent with the classical description 
of C-boutons in cat spinal cord2.
The NRG1-ErbB module is found in C-boutons and is differentially compartmentalised with 
other signalling proteins. Using several specific antibodies we analysed the precise distribution of sev-
eral proteins that are known to be clustered at the C-type synapse. C-bouton sites were identified by labelling 
presynaptic terminals with vesicular acetylcholine transporter (VAChT, Figs 1 and 2). In close association with 
VAChT-positive spots, we confirmed the presence of NRG1, M2-type muscarinic acetylcholine receptors (M2 
AChRs), S1Rs, the Kv2.1 delayed rectifier K+ channel (Kv2.1), and the postsynaptic SK channel SK3. All of these 
were present in oval patches distributed throughout the soma and in proximal dendrites of large spinal cord 
MNs, representing the postsynaptic compartment of C-bouton (Fig. 1a–d). In agreement with our previous 
work18, non-cholinergic (i.e. glutamatergic, serotoninergic and GABAergic) afferent synapses on MNs did not 
express the particular assembly of postsynaptic molecules seen in cholinergic terminals (not shown). In addi-
tion, ultrastructural immunolabelling (Fig. 1e,f) followed by the stereological analysis37 of gold nanoparticles 
distribution confirmed that, within C-bouton, NRG1 was accumulated postsynaptically in the SSC (for total 
Chi-square = 19,337.8 and df = 4, p < 0.0001, there is a preferential labelling in SSC, n = 20 C-bouton synapses; 
see Fig. 1f).
C-bouton-associated protein molecules were assembled in a highly ordered manner and segregated into spe-
cific microdomains. This was clearly shown after confocal imaging of multi-labelled C-boutons using the highest 
resolution settings. Our results complement those reported by Deardorff et al.19. Postsynaptic sites enriched in 
M2 cholinergic receptors were precisely aligned with the strongest signal for VAChT, indicating the areas with the 
maximum concentration of cholinergic vesicles at the presynaptic terminal (Fig. 2a–f). The areas most enriched 
in NRG1 were intercalated with microdomains displaying the maximal intensity for Kv2.1 or S1R immunola-
belling (Fig. 2g–p). In orthogonal projections of C-boutons, the S1R signal was usually detected in the form of 
a central saccule-like structure surrounded by smaller NRG1-containing spots (Fig. 2g–i). In addition, in some 
MNs, Kv2.1 immunoreactivity formed an additional bell-like line, externally surrounding the whole C-bouton 
area (Fig. 2q–s). This is in agreement with observations made in hippocampal neurons38,39. The segregated local-
ization of NRG1 and Kv2.1 in C-type synapses was further assessed after double immunolabelling. This analysis 
suggested that Kv2.1 subunits were located both in the postsynaptic membrane and in the SSC, although they 
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were clustered in separate domains than NRG1 (Fig. 2p). SK3 channel protein was also clustered in C-boutons 
from some, but not all, MNs; these, probably correspond to MNs innervating slow-twitch muscles6. In our sam-
ples, SK3 and Kv2.1 potassium channels appear to be localized in separate domains (Fig. 2t–y). All these results 
indicate that the postsynaptic machinery at C-boutons contains a unique mosaic of proteins that are spatially 
arranged in highly ordered, interdigitated, non-overlapping, microclusters. Using double immunogold labelling, 
the regions within the SSC enriched in NRG1 and S1R were clearly segregated; most of the particles were located 
at the SSC membrane. A minor proportion (9.7 ± 2.59%, n = 14 synapses) of nanogold particles were seen asso-
ciated with the postsynaptic membrane, suggesting that NRG1 may have been translocated from the SSC to the 
postsynaptic membrane (Fig. 3a–c). Double immunogold labelling was also applied to identify NRG1 in con-
junction with Kv2.1; results confirmed that both proteins reside postsynaptically in separate regions, with Kv2.1 
located at the periphery of clustered NRG1 (Fig. 3d). These data extend previous observations on the ultrastruc-
tural localization of Kv2.1 channels5,38. To improve C-bouton sampling in ultrathin cryosections, all these double 
labelling experiments were performed in hypoglossal MNs, as these are more densely packed than ventral horn 
MNs. We have already described that both morphological and immunocytochemical properties of C-boutons in 
hypoglossal MNs are virtually identical to those in spinal cord18.
By using several anti-ErbB2 or ErbB4 antibodies, positive immunolabelling in the presynaptic com-
partment of C-boutons was unambiguously observed in contrast to the postsynaptic localisation of NRG1 
(Fig. 4a–c). Although this immunoreaction was sometimes faint and imprecise, it became more prominent when 
Figure 1. NRG1 protein is associated with the C-bouton proteins VAChT and S1R, and localized in SSC 
at postsynaptic region. (a–d) Squashed MNs triple immunolabelled for NRG1 (green), S1R (red) and VAChT 
(blue). The three molecules colocalise at C-boutons, but S1R is also present as non-synaptically-associated 
particles. The nuclei are delimited by a dashed line. Individual RGB channels of the indicated MN (arrow) are 
shown in (a-c). When individual C-boutons are observed at high magnification (square delimited in (d)), sites 
containing S1R are segregated from NRG1-positive patches, and delimited by presynaptic VAChT. (e and f) 
NRG1 accumulates in the SSC (arrows) as shown in spinal cord MNs after ultrastructural immulolabelling by 
a pre-embedding (e) or post-embedding immunogold (f) procedure. Scale bars: in (c) = 10 μ m; (d) = 20 μ m; in 
(e) = 250 nm; in (f) = 50 nm.
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Figure 2. C-bouton proteins NRG1, S1R, Kv2.1 and SK3 are differentially clustered at the postsynaptic 
region. (a–f) MN somata (encircled in (a) and (d)) showing C-bouton synapses immunostained for 
simultaneous visualisation of M2 AChR (green), SR1 (red) and VAChT (blue); an enlargement of the square 
delimited C-bouton is shown in (b,c,e,f) in either separate or combined channels; note the similar distribution 
of the M2 AChR and VAChT sites; this contrasts with the differential localisation of M2 AChR and SR1; 
two channel merged images are shown in (a,d,e and f). (g,h) Sites containing S1R locate in a central region 
surrounded by NRG1-positive patches, separately delimited from presynaptic VAChT. (h) Volume rendering 
of a C-bouton site showing the differential distribution of NRG1 (green) and S1R (red) is depicted. (j–o) 
Clusters of NRG1 (green) and Kv2.1 (red) display a complementary distribution within the VAChT-positive 
(blue) C-bouton; two and three channel merged images are shown in (m,n) and (o), respectively. (p) A detail 
of a C-bouton, double labelled for NRG1 (green) and Kv2.1 (red), is subjected to pixel profile analysis along 
the depicted line; note the absence of colocalisation between the two interdigitating signals. (q–s) Surface 
of squashed MN cell body (delimited by a dotted line) displaying the distribution of clustered Kv2.1 (red) 
potassium channels in VAChT-immunolabelled C-boutons (blue) (q); the lateral and orthogonal projections 
of enlarged C-boutons are shown in (r) and (s), respectively; the postsynaptic localisation of Kv2.1 channels 
is shown in front of a VAChT-positive terminal in (r); the belt like arrangement of Kv2.1 potassium channels 
around the VAChT-labelled C-bouton can be seen in (s). (t–y) A triple immunolabelled C-bouton showing 
the differential distribution of SK3 Ca2+-dependent K+ (green) with respect to Kv2.1 K+ (red) channels in a 
VAChT-delimited (blue) synaptic region; two and three channel merged images are shown in (w,x), and (y) 
respectively. Scale bars: in (d) = 10 μ m (also applicable to (a)); in (h) (valid for (g)), (i), (o), (p), (s) (valid for (r)) 
and (y) = 1 μ m; in (q) = 20 μ m.
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phosphospecific antibodies were used and, in particular, after performing tyramide signal amplification (TSA) 
(Fig. 4d–f, and Supplementary Fig. 2). The immunostaining obtained with the anti-phosphorylated ErbB2 or 
ErbB4 antibodies overlapped the presynaptic VAChT positivity in most, although not all, C-boutons (Fig. 4d). 
However, unphosphorylated ErbB2 and ErbB3 were not detected in association with VAChT-positive puncta. 
The plot profile and co-localization analysis showed a high degree of coincidence between phospho-ErbB2 and 
VAChT signals (Pearson’s R = 0.72, Fig. 4i,j). By contrast, the same analysis confined NRG1 to the postsynaptic 
compartment, and as being clearly distinct from the VAChT signal (Pearson’s R = 0.33, Fig. 4g,h). The intensity of 
ErbB immunoreactivity varied among the individual cholinergic terminals, ranging from negative or very weak 
to intense. In addition to the synaptic immunolabelling, ErbB2 and ErbB4 were also detected in MN cell bodies 
and neuropil, particularly when TSA was used. The association between either NRG1 or p-ErbB2 with VAChT 
immunolabelled C-boutons can be further appreciated after volume rendering imaging (Fig. 4k,l).
This overall spatial distribution of C-bouton-associated proteins is depicted in Fig. 5(a,b), based on a model 
that we proposed after examining 3D reconstructions of multi-labelled C-bouton synapses.
The total number of C-boutons per MN soma was calculated from 3D reconstructed squash preparations of 
thick (200 μ m) spinal cord slices from adult mice. After analysing 14 MNs, we found an average of 3.11 ± 0.30 
(in 100 μ m2 of MN soma surface; C-type synapses were visualized by VAChT immunostaining). Similar numbers 
were found after evaluating clustered NRG1-positive particles (3.60 ± 0.29/100 μ m2 of MN soma surface) and 
synaptically-associated SR1-positive spots (2.92 ± 0.28/100 μ m2). The average size of the synaptic area contain-
ing the distinct C-bouton markers was as follows: VAChT = 6.87 ± 0.25, n = 184; NRG1 = 5.41 ± 0.20 n = 203; 
SR1 = 4.30 ± 0.20, n = 153 (all in μ m2; with n corresponding to the number of C-bouton examined). We further 
determined whether these morphometric parameters differed when the analysis was specifically performed in 
MN subtypes innervating fast or slow muscles. MN pools were identified after retrograde tracing by injecting 
fluorescent cholera toxin B into either tibialis anterior (TA) or soleus muscles (Supplementary Fig. 3). The results 
indicated that NRG1-positive puncta were more abundant, although smaller, in fast type TA-innervating MNs 
than in slow type MNs contacting the soleus muscle.
Development of C-bouton-associated NRG1. Developmental changes in C-bouton associated proteins 
such, as Kv2.1 and M2 AChRs occur postnatally, together with the functional maturation of the motor system40. 
We analysed the developmental expression of NRG1 in the spinal cord in relation to the other C-bouton asso-
ciated molecules, such as VAChT and SR1 (Fig. 6a–f). Small (< 1 μ m2), but abundant, NRG1 positive discrete 
puncta were detected prenatally at E18 (Fig. 6c,d). Many of these particles did not show any association with 
Figure 3. Immunolabelling using nanogold particles of ultrathin cryosection for the ultrastructural 
localisation of NRG1, S1R and Kv2.1 channels at C-boutons. To facilitate the localisation of C-boutons, the 
analysis was performed in hypoglossal MNs. A detail of the organization of compartments at C-bouton synapses 
in negatively stained cryosections is depicted in (a) 1 = presynaptic (green), 2 = intersynaptic extracellular space 
(yellow), 3 = postsynaptic cytoplasmic compartment lodged between postsynaptic membrane and subsynaptic 
cistern (SSC, red), 4 = SSC (violet), and 5 = MN cytoplasm (red). The same colour code is used in (b–d).  
(b,c) Double immunolabelling for NRG1 and SR1; NRG1 (red arrows) is mainly associated with SSC forming a 
cluster segregated from SR1 (blue arrows). (c) A minor proportion of gold particles (encircled) are located at the 
postsynaptic membrane. (d) nanogold particles labelling Kv2.1 are located on the periphery (yellow arrows) of 
C-bouton enriched with a NRG1 cluster (red arrows). Scale bar: in (a,c) = 25 nm; in (b,d) = 50 nm.
www.nature.com/scientificreports/
6Scientific RepoRts | 7:40155 | DOI: 10.1038/srep40155
Figure 4. C-bouton type synapses contain the NRG1/ErbB signalling module. (a,b,c) NRG1 (red) is 
concentrated at the C-bouton postsynaptic site adjacent to VAChT (blue) positive cholinergic terminals.  
(d,e,f) show that p-ErbB2 (red) is present in the presynaptic site of many, but not all, cholinergic terminals 
labelled with VAChT antibody (blue). In (a,c,d,f) MN somata are visualised with fluorescent Nissl staining 
(green). In (b) and (c), orthogonal and lateral projections, respectively, of a C-bouton immunolabelled for 
NRG1 and VAChT are shown; the dissociation of the two signals is evidenced after colocalisation (g) and pixel 
profile analysis (i). In (e) and (f) orthogonal and lateral projections, respectively, of a C-bouton immunolabelled 
for p-ErbB2 and VAChT are also shown; the overlapping of two signals is evidenced after a colocalisation (h) 
and pixel profile analysis (j). Colocalised pixels are displayed in white in (g) and (i); the low numbers of white 
pixels in (g) corresponds to the boundary between pre- and post-synaptic compartments, which are overlapped 
due to mechanical folding and compression inherent to tissue processing. (k,l) represents the volume rendering 
of serial optical sections (0.5-μ m thick) from a MN showing the distribution of NRG1 (red in (k)) and p-ErbB2 
(red in (l)), and VAChT (blue) co-labelled C-boutons. Scale bars: in (d) = 10 μ m (also applicable to (a)); in 
(f) = 3 μ m (also applicable to (b, c, e)); in (l) = 5 μ m (valid for (k)).
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VAChT-positive presynaptic terminals. In addition, at this stage, large patches of NRG1 (> 3 μ m2) were often seen 
adjacent to the MN surface, although they were not related to VAChT-labelled nerve terminals. These NRG1 clus-
ters, underwent a conspicuous remodelling becoming virtually absent from P1 onwards (Fig. 6c,e). During the 
postnatal period, the size of the NRG1 clusters increased progressively, reaching a plateau at P18 (Fig. 6a,b,f). At 
this age, virtually all of the NRG1 clusters were associated with presynaptic cholinergic terminals. In agreement 
with Mavlyutov et al.41, C-bouton-associated S1R immunoreactivity began only after the second week of postnatal 
development (Fig. 6a,b). In the spinal cord MNs of aged mice, the density and size of the C-bouton presynaptic 
terminals were markedly reduced, whereas this did not occur for the postsynaptic proteins NRG1 and S1R.
In order to analyse NRG1 and C-bouton synapse formation in an in vitro model, we performed long-term cul-
tures of dissociated spinal cord neurons. We assumed that the presence of a mixed neuronal population would be 
necessary to develop C-bouton-like cholinergic afferents and that the presence of glial cells would provide trophic 
support for promoting long-term MN survival and differentiation. In these cultures, highly branched and large 
MNs were identified after immunostaining with either SMI32 or anti-ChAT antibodies following 14–28 days 
in vitro (Fig. 7a,b). These MNs exhibited neurite outgrowth over long distances and formed an interconnected 
network with abundant neuritic-neuritic and neuritic-somatic junctures, which displayed the synaptic marker 
synaptophysin (Syn) and appeared distributed in discrete puncta. Many of these were glutamatergic boutons 
because they also contained VGluT1 or VGluT2 (Fig. 7d–f). Very few MNs showed VAChT-positive axo-somatic 
or axo-dendritic synaptic contacts adjacent to spots containing NRG1 (Fig. 7g,h). By contrast, a variable number 
of spots with a prominent NRG1 signal was observed in many MNs without any association with the presynaptic 
nerve terminal markers Syn and VAChT (Fig. 7i–j). These non-synaptic associated NRG1 patches were often in 
close proximity to GFAP-positive astroglial processes (Fig. 7c). It is interesting to note that somato-dendritic 
NRG2 puncta have been described in association with astroglia in cultured hippocampal neurons39. Overall, this 
in vitro model recapitulates some of the early events leading to C-bouton formation in vivo, but it is only able to 
generate afferent cholinergic synapses on a minor proportion of MNs.
Disruption of postsynaptically-clustered NRG1 in axotomised MNs together with microglial 
activation. The retrograde response of neurons to peripheral nerve interruption is associated with prominent 
changes in ER organisation42, in the plasticity of synaptic inputs combined with the activation of perineuronal glial 
cells43,44, and increased excitability22. As these changes may be related to altered C-bouton function22, we analysed 
the impact of sciatic nerve transection on postsynaptic NRG1. In spinal cord sections, the pool of axotomised 
MNs was readily identifiable after IBA1 immunostaining due to the notable and early recruitment of microglia 
around lesioned MN somata (Fig. 8a). As shown in Fig. 8b–f, a progressive and transient disintegration of NRG1 
clusters occurred in axotomised MNs associated with perisomatic microglial activation starting 24 h after nerve 
injury. Although the reduction in size of NRG1 immunoreactive profiles reached its maximum 14 days following 
axotomy, the density of individual clusters was only slightly changed. By 30 days post-lesion, the size of the NRG1 
profiles found in basal conditions showed a recovery, reaching similar values to controls. Correlative ultrastruc-
tural alterations have been reported in the SSC of axotomised MNs45. The size of the VAChT immunoreactive 
profiles present in the presynaptic compartment of afferent nerve terminals contacting axotomised MNs showed 
changes similar to those found for NRG1 (area of VAChT-delimitated C-bouton in μ m2: control = 6.80 ± 0.20 
[n = 184], 14 days post-axotomy = 3.08 ± 0.14 [n = 114], and 30 days post-axotomy = 7.45 ± 0.32 [n = 153]; 
control vs. 14 days post-axotomy, p < 0.001; control vs. 30 days post-axotomy, non-significant; Student’s t-test). 
By contrast, the number of VAChT positive terminals declined more markedly (> 45%, 7 days after axotomy) 
than that of NRG1 clusters (number of VAChT positive profiles per 100 μ m2: control = 3.19 ± 0.3 [n = 14], 7 
days post-axotomy = 1.46 ± 0.16 [n = 10]; p < 0.001, Student’s t-test). We observed that during microglial recruit-
ment and activation around axotomised MNs, C-bouton sites exerted an apparent chemoattractant-like effect 
Figure 5. Model showing the possible distribution of some proteins specifically concentrated at C-type 
synapses. The synapse is displayed in orthogonal (a) and lateral (b) views. The different sub-compartments in 
which proteins accumulate are depicted according to the indicated colour code. Since the mechanism by which 
postsynaptic NRG1 and presynaptic ErbBs interact is unknown, two possible routes are indicated with question 
marks: one mediated by exosomes, and the other involving a juxtacrine interaction.
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on microglial profiles (Figs 8b,c and 9a–c). When the proportion of distinct types of presynaptic terminals con-
tacted by microglial profiles was measured in MN somata 7 days after axotomy (Fig. 9d–g), we found that more 
than 50% of VAChT-positive or VGluT1-positive terminals were intimately associated with microglial processes, 
whereas a much lower proportion of microglial profiles were in contact with GABAergic or serotoninergic syn-
apses (Fig. 9h); data concerning the relative density of the distinct types of afferents do not account for these dif-
ferences (not shown). In addition to motor axons, peripheral nerve injury leads to the interruption of the sensory 
proprioceptive axons that establish monosynaptic VGluT1-positive afferent connections with MNs46. It would not 
Figure 6. Age-related changes in the morphometrical parameters of the C-bouton associated proteins 
NRG1, VAChT and S1R. The area and density of the immunolabelled protein profiles are shown in (a) and 
(b), respectively. (c) Relative frequency histogram of NRG1 clusters for late embryonic (E18), newborn (P1) 
and P18 MNs; note that the large (> 3 μ m2) NRG1 clusters seen on E18 animals are substantially reduced by P1. 
(d–f) Representative images of MN somata used for quantification in (c); arrow in (d) indicates a large cluster 
of NRG1 on an E18 MN; MN somata are delimited by dashed lines; note that at P18 (f), C-bouton-associated 
clusters of NRG1 were only seen on large MNs (*), but not on smaller cell bodies corresponding to interneurons 
(arrow). In all the graphs, the data are shown as mean ± SEM. One-way analysis of variance (Bonferroni’s post-
hoc test) was used for statistical analysis. Scale bar in (f) 20 μ m (valid for (d,e)).
www.nature.com/scientificreports/
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be surprising if there were an association between microglia with degenerating and presumably chemoattractant 
VGluT1-containing terminals47. Nevertheless, the C-bouton spatial specificity as a target for microglial migra-
tion is less expected, because the interneurons, from which these terminals originate, are not directly damaged 
by axotomy. This apparent chemotactic activity is probably related to the complex arrangement of molecules 
and signal-transduction pathways inherent to C-boutons. This may represent an early event in the inflammatory 
response to injured MNs that could contribute to the generation of a perisynaptic environment that could play a 
Figure 7. Formation of synaptic afferents in long-term cultures of spinal cord neurons. MNs are identified 
with SMI32 or ChAT immunostaining. (a) A representative highly branched SMI32 (green) positive MN. 
(b) A ChAT positive (red) MN showing multiple afferent synaptic boutons detected by synaptophysin (Syn, 
green) labelling. (c) A ChAT positive (red) MN displaying NRG1 clusters (green) which, in some cases, are in 
contact with GFAP positive (blue) astroglial profiles (arrows). (d–f) A ChAT positive (red) MN with multiple 
Syn positive (green) synaptic contacts in which many contain VGluT2 (blue). (g,h) A ChAT positive MN 
(red) showing VAChT positive (blue) cholinergic afferent boutons in close association with NRG1 (green) 
positive clusters, as detailed (encircled) in the enlarged region delimited in (h). (i,j) A ChAT positive MN 
(red) showing NRG1 (green) positive clusters which are not associated with VAChT (blue) positive puncta, as 
shown (encircled) in the enlarged region delimited in (j). Scale bars: in (a and b) = 20 μ m; in (c) = 10 μ m; in 
(f) = 20 μm (valid for (d,e)); in (j) = 20 μ m (valid for (g,h,i)).
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Figure 8. C-bouton-associated NRG1 clusters are disrupted after peripheral nerve transection together 
with microglial activation. (a) A lumbar spinal cord transverse section 7 days after unilateral sciatic nerve 
transection; note the microglial reaction (IBA1, red) around the ventral horn MNs (encircled) and in the dorsal 
horn (arrows); the section was Nissl-counterstained (blue). (b,c) Detail of spinal MNs corresponding to the 
contralateral (b) and ipsilateral (c) ventral horns following nerve axotomy stained for NRG1 (green), IBA1 (red) 
and Nissl (blue); microglial cells are recruited around axotomised MNs (c), in which NRG1 clusters are in the 
process of fragmentation. Note the tendency of microglial profiles to contact altered NRG1 clusters. The time 
course of changes in the morphometrical parameters of NRG1 clusters after sciatic nerve axotomy are shown in 
(d,e). Changes in the perisomatic-microglial covering of MNs are measured at the same time points (f). In all 
the graphs, data are shown as mean ± SEM. **p < 0.01, ***p < 0.001, one-way analysis of variance (Bonferroni’s 
post-hoc test); n = 27–113 (d); n = 7–15 (e) and n = 10–18 (f). Scale bar: in (a) = 250 μ m; in (c) = 20 μ m (valid 
for (b)).
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role in determining MN survival or degeneration. Further work is necessary to determine the molecular cues that 
attract microglial processes to C-type synapses following nerve injury.
Discussion
With the emergence of new data about the C-bouton structure and function, and its possible relevance to MN 
pathology, there has been considerable recent interest in this type of synapses19,48. Here, we extend our previous 
report showing that the NRG1-ErbB2/3 signalling module is expressed at C-boutons18, by providing a more 
Figure 9. Recruitment of microglial cells to axotomised MNs exhibits apparent positive chemoattraction 
to C-bouton sites. (a) IBA1 positive microglial profiles (red) near the soma of a 24 h axotomised MN show a 
high number of contacts with NRG1 positive C-bouton sites (green). (b) After colocalisation analysis, NRG1 
clusters enwrapped by microglia are displayed in white. (c) 3D volume rendering showing the relationship 
between microglial processes and NRG1 clusters in the MN displayed in (a); the limit of MN soma is delineated 
(dashed lines). (d–g) The spatial relationship between microglial profiles and different afferent boutons on 7-day 
axotomised MNs is analysed after immunostaining for IBA1 (red) and the indicated synaptic proteins (green); 
MN somata were identified by Nissl staining (blue). The green and red signals were binarised for analysis as 
shown in each adjacent panel. (h) Graph showing that microglial profiles exhibit a preference to contact NRG1-
labelled C-boutons and/or VGluT1-containing synapses, rather than to VGAT-immunolabelled GABAergic 
or serotoninergic (5-HT) synapses; plotted data are also shown as mean ± SEM; *p < 0.05, ***p < 0.001, one-
way analysis of variance (Bonferroni’s post-hoc test). Scale bars: in (b) = 20 μ m (valid for (a)); in (c) = 5 μ m; in 
(g) = 20 μ m (valid for (d,e,f)).
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detailed analysis of the compartmentation of these molecules and their relation with other proteins that are 
known to be specifically clustered at this synaptic site. The SSC, the ER-related organelle that anatomically defines 
C-boutons, is the site at which some of these proteins accumulate. This is the case of SR1, Kv2.1 and NRG1. In 
addition, we show that, within the SSC, these proteins reside in segregated regions that probably represent dis-
tinct, highly specific spatial domains. This may define spatially-restricted fields for different signal-transduction 
pathways in the post-synaptic compartment, which are specifically arranged in relation to presynaptic proteins. 
This would be consistent with the emerging concept of “trans-synaptic nanocolumns”49. One so far unsolved 
question that deserves further attention is whether SSC-resident proteins can translocate and/or interact with 
the post-synaptic membrane, as appears to be the case for Kv2.1 and SR1. Kv2.1 is a major component of delayed 
rectifier K+ channels which are involved in the modulation of neuronal excitability in various neuronal types5. 
In agreement with our findings, Kv2.1 channels have sometimes been identified in the most peripheral region 
of the SSC38,39. These data indicate that Kv2.1 clusters are strategically situated at specific somatic synapses in 
conjunction with other signalling proteins including S1R and NRG1. S1R is a highly dynamic chaperone-like 
protein present in the SSC, which is involved in ALS when mutated50. S1R may operate here in a similar way 
to that described for mitochondrion-associated ER membrane in Ca2+ signalling via IP3 receptors, perhaps in 
collaboration with M2-receptor cholinergic activation50–52. Thus, by modulating spatiotemporal calcium signals, 
S1Rs may regulate either voltage-gated calcium channels or potassium channels53, both of which have an impact 
on neuronal excitability through a mechanism that acts via either G-protein-dependent M2 receptor activation or 
channel phosphorylation. In addition, it should be taken into account that highly clustered Kv2.1 phosphorylated 
proteins may have non-conducting, as yet undefined, functions54. It has been suggested that these Kv2.1 clusters 
could be sites for the delivery of membrane proteins to the cell surface55. Accordingly, Kv2.1 platforms may play a 
role as an organizer of the complex molecular assembly at the C-bouton postsynaptic site, regulating site-directed 
vesicle-membrane trafficking. This would perhaps explain the particular, belt-like, distribution of Kv2.1 protein, 
surrounding the whole oval-shaped C-bouton site.
The existence of NRG1 within the SSC facing ErbBs in association with cholinergic terminals is a recently 
described observation18 that we have extended on here. It has also been recently shown that NRG2 accumulates 
in the SSCs of cortical interneurons expressing ErbB439. In this case, NRG2/ErbB4 signalling appears to regulate 
NMDA receptors in an autocrine manner. Although our data indicate that the main pathway for NRG1-ErbBs 
signalling at C-boutons may be retrogradely directed from post- to pre-synaptic compartments, we cannot rule 
out the possibility of additional autocrine NRG1 mediated signalling in MNs, as ErbBs are also expressed in these 
cells. Although our results concerning the localization of ErbBs contrast with those reported by Lasiene et al.35 
using non-phosphospecific anti-ErbBs antibodies, we are confident of our results since they were extensively 
replicated and analysed using several different antibodies. The strongest presynaptic ErbB signal was obtained 
when phosphospecific anti-ErbB2 and ErbB4 antibodies were used; this points to the activation of this pathway 
in a particular subset of C-boutons. Furthermore, the NRG1/ErbB signalling system is also involved in a variety of 
well-established roles within the neuromuscular system. For example the MN-derived NRG1 pathway is critical: 
(i) to the development of Schwann cells and myelination56, (ii) to the development and plasticity of neuromuscu-
lar junctions57 and, (iii) perhaps also, to the induction of local AChR synthesis58,59. The anti-NRG1 antibody used 
in this work recognises a C-terminal epitope which is common within the different NRG-1 isoforms. The above 
mentioned actions are mainly mediated by the type III NRG1 (NRG1-III), which is the main isoform expressed 
in MNs58,60–63. It is therefore likely that the isoform we detected in C-boutons corresponds to NRG1-III, which 
is characterised by a cysteine-rich domain (CRD) determining a second N-terminal transmembrane domain. 
Signalling mediated by this membrane-anchored isoform may take place in a contact-dependent juxtacrine man-
ner, through either the full length or truncated protein. Paracrine signalling via the proteolytic liberation of the 
EGF-like domain has also been described64. How post-synaptic NRG1 at C-boutons gains access to presynaptic 
ErbB receptors is not yet understood. Intercellular vesicular transmission mediated by exosomes may have a 
role in some forms of trans-synaptic communication65. We have observed intersynaptic multivesicular bodies at 
C-boutons with exosome-like vesicles containing NRG118. It should be noted that the intersynaptic trafficking of 
large vesicles has already been documented in C-type synaptic terminals66. Another aspect that should be taken 
into account is the possibility of ErbBs-elicited NRG1 back signalling after the proteolytic release of the intracel-
lular domain of NRG1, which may act as a transcriptional factor capable of regulating neuronal survival67.
Surface-associated NRG1 spots appeared in developing MNs on E18, at the same time as VAChT-positive 
perisomatic puncta. This is consistent with reported data on the development of cholinergic terminals in MNs68. 
However, the transient existence of large and un-innervated NRG1 spots in immature MNs suggests that SSC 
development is a cell autonomous process, which undergoes remodelling induced by nerve terminals during 
cholinergic synaptogenesis. In adults, SSC markers, including NRG1, are progressively lost after peripheral nerve 
section, together with microglial activation and synaptic loss. This is consistent with the decrease in NRG1-III 
expression found in the facial nucleus after axotomy14 and also with the redistribution of C-bouton-associated 
Kv2.1 channels after peripheral nerve injury22.
Another interesting question that has derived from our study is whether C-bouton has a particular role in 
the orchestration of a neuroinflammatory response. Our results suggest that C-bouton associated molecules act 
as cues for the attraction of microglial processes which, in turn, remove the synaptic terminals. In addition to 
motor axons, peripheral nerve injury leads to the interruption of the sensory proprioceptive axons that establish 
monosynaptic VGluT1-positive afferent connections with MNs46. It would not be surprising if there were an asso-
ciation between microglia with degenerating and presumably chemoattractant VGluT1-containing terminals47. 
Nevertheless, the C-bouton spatial specificity as a target for microglial migration is less expected, because the 
interneurons, from which these terminals originate, are not directly damaged by axotomy. This apparent chem-
otactic activity is probably related to the complex arrangement of molecules and signal-transduction pathways 
inherent to C-boutons. At the molecular level, one candidate for this action could be the NRG1/ErbBs signalling 
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pathway. It has been shown that ErbB receptors are expressed in microglia and that NRG1 is a chemotactic factor 
for microglia in vitro; the NRG1/ErbBs module is specifically activated in spinal cord dorsal horn during micro-
glial reaction following peripheral nerve injury69. This may represent an early event in the inflammatory response 
to injured MNs that could contribute to the generation of a perisynaptic environment that could play a role in 
determining MN survival or degeneration. However, we did not observe ErbB positive immunostaining in acti-
vated microglia around axotomised MN somata (data not shown).
Our findings reveal the highly specific arrangement of C-bouton-associated proteins, their disruption in 
acutely lesioned MNs and their putative role in regulating the neuroinflammatory response, and emphasize the 
relevance of this hitherto poorly understood structure in the physiology and pathology of MNs. The significance 
of NRG1-ErbBs retrograde signalling in C-type synapse deserves particular attention in the future as a putative 
new target for therapy in ALS.
Material and Methods
Animals, surgical procedures and tissue preparation. CD1 mice were purchased from Harlan 
Laboratories (Castellar del Vallès, Barcelona, Catalonia, Spain). All the animal experimentation procedures were 
performed according to the European Committee Council Directive and the norms established by the Generalitat 
de Catalunya (published as a law in the Diari Oficial de la Generalitat de Catalunya [DOGC] 2073, 1995). All 
the experiments were previously evaluated and approved by the Committee for Animal Care and Use of the 
University of Lleida.
For axotomy experiments in adult mice (postnatal day 60), the sciatic nerve was transected at the femoral level 
and its proximal stump was ligated in order to prevent spontaneous reinnervation.
To retrograde label MNs innervating the tibialis anterior (TA) and soleus muscles, cholera toxin B conjugated 
with either AlexaFluor 555 (for TA) or AlexaFluor 488 (for soleus) (1 μ g/μ l in phosphate buffer [PB], Molecular 
Probes, Eugene, OR, United States) was used. After surgical exposure of the muscles, volumes of 6 or 3 μ l of CTB 
solution were respectively injected into the right TA or left soleus. One day after injection, the animals were fixed 
by transcardial perfusion, as described below.
All surgical manipulations were performed under anaesthesia, with a combination of ketamine (100 mg/Kg) 
and xylazine (10 mg/Kg). To minimise suffering, the animals were subjected to postoperative analgesia with intra-
peritoneally injected buprenorphine (0.05 mg/Kg).
Spinal cord cultures. Primary cultures of dissociated spinal cord from CD1 mouse embryos (embryonic 
day 13) were prepared as previously described70 with minor modifications. Briefly, the lumbar spinal cords 
were dissected and the meninges and ganglia removed. Dissociated cells were plated at a density of 300,000 
per well in 12-well Nunclon culture dishes containing round glass coverslips coated with a poly-D-lysine plus 
Matrigel basement membrane matrix (Corning, Bedford, MA). The cells were then maintained in minimum 
essential medium (Gibco, Waltham, USA) enriched with 5 g/l glucose and supplemented with 3% horse serum, 
10 ng/ml nerve growth factor and B27 medium (Gibco). On day 6, the cultures were treated with 1.4 μ g/ml 
cytosine-β -arabinoside (Sigma-Aldrich, Saint Louis, MO) in order to minimise the growth of non-neuronal cells. 
Cultures kept for 14–28 days in vitro were washed in PBS, fixed in 4% paraformaldehyde (PFA) in 0.1 M PB (pH 
7.4) for 1 h, and processed for immunofluorescence.
Multiple fluorescent labelling and confocal microscopy. Tissue samples were obtained from mice 
transcardially perfused with 4% PFA in 0.1 M PB, pH 7.4. Lumbar spinal cord samples were dissected, post-fixed 
in the same fixative overnight at 4 °C, and then cryoprotected with 30% sucrose in 0.1 M PB containing 0.02% 
sodium azide. Transverse cryostat sections (16-μ m thick) were collected on gelatin-coated glass slides.
Sections were then permeabilised with phosphate-buffered saline (PBS) containing 0.1% Triton X-100 for 
1 h, blocked with either 10% normal goat serum or normal horse serum in PBS for 1 h at room temperature, and 
then incubated overnight at 4 °C with an appropriate primary antibody mixture. The primary antibodies used are 
indicated in Table 1.
Once previously washed with PBS, sections were incubated for 1 h with a combination of appropriate sec-
ondary fluorescent antibodies labelled with one of the following fluorochromes (1/500): Alexa Fluor 488, Alexa 
Fluor 546, (Molecular Probes, Eugene, OR, United States), Cy3, or Cy5 (Jackson Immuno Research Laboratories, 
West Grove, PA, United States). Finally, the spinal cord sections were labelled with blue fluorescent NeuroTrace 
Nissl staining (1:150; Molecular Probes) and mounted using an anti-fading medium containing 0.1 M Tris-HCl 
buffer (pH 8.5), 20% glycerol, 10% Moviol, and 0.1% 1,4-diazabicyclo[2,2,2]octane. For ErbB visualisation, some 
sections were processed using the tyramide signal amplification (TSA), following the procedure recommended 
by the manufacturer (ThermoFisher, Waltham, MA).
For the 3D analysis of C-boutons in individual MNs, a squash procedure71 was used. Fixed spinal cords were 
sectioned with a vibratome (200-μ m thick). Sections were collected in PB, and placed on SuperfrostPlus micro-
scope slides (Menzel-Glaser, Germany). A coverslip was then applied to the tissue which was squashed with 
forceps. The preparations were then frozen in liquid N2, and, after removing the coverslip, the slides with the 
retained tissue were fixed in methanol at − 20 °C for 10 min. After washing with PBS, immunocytochemistry was 
performed as described above.
The slides were then examined under a FluoView FV-500 or FluoView FV-1000 Olympus laser-scanning con-
focal microscopes (Olympus, Hamburg, Germany). The MNs were imaged after obtaining optical sections (0.5 
or 1 μ m) of cell bodies. Digital images were analysed with either Visilog 6.3 software (Noesis, Orsay, France) or 
ImageJ software (US National Institutes of Health, Bethesda, MD, USA). For colocalization analysis the ImageJ 
plugin developed by Pierre Bourdoncle (bourdoncle@ijm.jussieu.fr) was used.
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Immunolabelled profiles of NRG1 and of the different protein markers examined were then manually counted 
on the screen for each MN soma. The area and perimeter of MN somata, and microglial profiles covering the MNs 
were also manually measured. The number of synaptic boutons contacting activated microglia in axotomised MNs 
was evaluated by image analysis (ImageJ). After application of the outline tool on binarised IBA1 images, these 
were merged with those corresponding to binarised synaptic boutons: the number of boutons contacting periso-
matic microglial profiles was manually counted. Three-dimensional reconstructions were performed using Bitplane 
(Imaris, Bitplane, CT, USA) on 0.5-μ m thick Z step obtained with the confocal microscope. The digital images were 
edited using FV10-ASW 3.1 Viewer (Olympus) and Adobe Photoshop CS4 (Adobe Systems Inc, San Jose, CA).
Electron microscopy. Some of the animals were perfused either with1% PFA and 1% glutaraldehyde in 
0.1 M PB (pH 7.4) for conventional electron microscopy or with 4% PFA and 0.2% glutaraldehyde in 0.1 M PB for 
immunoelectron microscopy.
For conventional electron microscopy, dissected tissues were postfixed in 1% OsO4 and processed for Embed 
812 embedding according to standard procedures. Ultrathin sections were counterstained with uranyl acetate 
and lead citrate.
For ultrastructural immunolabelling of NRG1, either pre-embedding or post-embedding (freeze substitution 
and low temperature embedding in Lowicryl HM20 resin [Electron Microscopy Sciences, Hatfield, PA, USA]) 
procedures were used, as previously described18. Double immunolabelling of NRG1 in combination with SR1 
or Kv2.1 was performed in ultrathin cryosections obtained with a Leica EM FC cryoultramicrotome and pro-
cessed according to established methods72,73. To facilitate the localisation of C-boutons in ultrathin cryosections, 
hypoglossal, instead of spinal cord, MNs were analysed in some cases. To do this, samples from brainstem or 
spinal cord were sectioned with a vibratome (200-μ m thick), and regions containing either hypoglossal nuclei or 
ventral horn were microdissected. Ultrathin cryosections were labelled using rabbit anti-NRG1 antibody (1:50; 
Santa Cruz Biotechnology, sc-348) in combination with either mouse anti-Kv2.1 (1:30; NeuroMab, 73014) or 
mouse anti-S1R (1:10; Santa Cruz Biotechnology, sc-137075). After washing, samples were incubated with 12 nm 
gold-conjugated goat anti-rabbit IgG (1:30; Sigma Aldrich) and 5 nm gold-conjugated goat anti-mouse IgG (1:30; 
Sigma Aldrich). Controls, omitting the primary antibody, were also performed. Observations were performed 
with either a Jeol JEM 1400 (Jeol, Tokyo, Japan) or a Zeiss EM 910 (Zeiss, Jena, Germany) transmission electron 
microscope. The subcellular distribution of immunoglod labelling of NRG1 in MNs was evaluated by the stereo-
logical analysis described by Mayhew37.
Target Source Host species
Used 
concentration
Choline acetyltransferase (ChAT) Millipore (Tamecula, CA) (AB 143) Rabbit polyclonal 1:200
Glial fibrillary acidic protein 
(GFAP) Abcam (ab4674) Chicken polyclonal 1:1000
Her4/ErbB4 Cell Signalling (#4795) Rabbit monoclonal 1:50
Ionised calcium-binding adaptor 
molecule 1 (IBA1) Abcam (ab5076) Goat polyclonal 1:500
Kv 2.1 voltage-gated potassium 
channel (Kv2.1) NeuroMab (73–014) Mouse monoclonal 1:100
M2 muscarinic receptor Alomone Labs (AMR-002) Rabbit polyclonal 1:100
Neu (C-18) (ErbB2) Santa Cruz Biotechnology (Sc-284) Rabbit polyclonal 1:50
NRG1 1α /β 1/2 Santa Cruz (sc-348) Rabbit polyclonal 1:200
Phospho-Her4/ErbB4 tyr1248 Cell Signalling (#4757) Rabbit monoclonal 1:50
p-Neu tyr1248 (p-ErbB2) Santa Cruz (sc-293110-R) Rabbit polyclonal 1:100
Sigma-1 receptor (S1R) Santa Cruz (sc-137075) Mouse monoclonal 1:50
Serotonin Chemicon (MAB352) Rat monoclonal 1:100
SK3 calcium-activated potassium 
channel (SK3) Alomone Labs (APC-025) Rabbit polyclonal 1:100
SMI32 Covance Research Products Inc (SMI32) Mouse monoclonal 1:5000
Synaptophysin Synaptic Systems (101 004)
Guinea pig 
polyclonal 1:500
Vesicular acetylcholine 
transporter (VAChT)
Synaptic Systems (139 
105)
Guinea pig 
polyclonal 1:500
Vesicular GABA transporter 
(VGAT)
Synaptic Systems (131 
004)
Guinea pig 
polyclonal 1:200
Vesicular glutamate transporter 1 
(VGluT1)
Synaptic Systems (135 
304)
Guinea pig 
polyclonal 1:500
Vesicular glutamate transporter 2 
(VGLuT2)
Synaptic Systems (135 
404)
Guinea pig 
polyclonal 1:500
Table 1.  Antibodies used for immunocytochemistry.
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Statistical analysis. The data are expressed as means ± SEM. The statistical analysis was assessed by either 
the Student’s t-test or one-way analysis of variance (ANOVA) followed by post hoc Bonferroni’s test. Chi-square was 
used for the stereological analysis of immunogold labelling. The level of significance was established at p < 0.05.
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